Aurobindo Pharma

Nifty slips, fails to defend 9,900-level

Aurobindo plans to launch 19 drugs in US in next 3 quarters

Aurobindo Pharma climbs after USFDA nod for OTC drug

Aurobindo Pharma gets USFDA nod for osteoporosis drug

Aurobindo Pharma gets shareholders' nod to raise up to $600 million

Aurobindo gets USFDA nod for multi disease treatment injection

Aurobindo gets USFDA nod to market generic Osteoporosis drug

Aurobindo Pharma to seek shareholders nod to raise $600 mn

Aurobindo may launch Tramadol tablets in US market

Aurobindo to expand product basket; eyes $3bn revenues by FY18

Aurobindo Pharma CEO Arvind Vasudeva resigns

Aurobindo gets USFDA nod to sell antibiotic oral suspension

Aurobindo divests Australian arm to Eris Pharma

Plethico shares soar 20% on settlement pact with Aurobindo

Aurobindo gets USFDA nod for Atracurium Besylate injections

Plethico to pay Aurobindo Pharma $23.3 mn to settle dispute

CCEA clears Glenmark, Aurobindo proposals worth Rs 4,187 cr

Aurobindo gets tentative nod from USFDA for Lacosamide tablets

Cos raise over $4-bn from QIP in FY15; $3-bn more in pipeline